12-49954663-C-T
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM5PP3_StrongPP5_Very_Strong
The ENST00000199280.4(AQP2):c.559C>T(p.Arg187Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000359 in 1,614,090 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R187H) has been classified as Likely pathogenic.
Frequency
Consequence
ENST00000199280.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AQP2 | NM_000486.6 | c.559C>T | p.Arg187Cys | missense_variant | 3/4 | ENST00000199280.4 | NP_000477.1 | |
AQP5-AS1 | NR_110590.1 | n.257-315G>A | intron_variant | |||||
AQP5-AS1 | NR_110591.1 | n.118-2575G>A | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AQP2 | ENST00000199280.4 | c.559C>T | p.Arg187Cys | missense_variant | 3/4 | 1 | NM_000486.6 | ENSP00000199280.3 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152204Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000477 AC: 12AN: 251492Hom.: 0 AF XY: 0.0000441 AC XY: 6AN XY: 135918
GnomAD4 exome AF: 0.0000356 AC: 52AN: 1461886Hom.: 0 Cov.: 32 AF XY: 0.0000358 AC XY: 26AN XY: 727246
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152204Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74352
ClinVar
Submissions by phenotype
Diabetes insipidus, nephrogenic, autosomal Pathogenic:3
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 01, 1994 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | 3billion | Feb 23, 2023 | The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.005%). The variant is located in a mutational hot spot and/or well-established functional domain in which established pathogenic variants have been reported. Missense changes are a common disease-causing mechanism. In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.84; 3Cnet: 0.99). Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000017828). Different missense changes at the same codon (p.Arg187Gly, p.Arg187His) have been reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000035695, VCV001481897). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. - |
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jul 21, 2021 | - - |
not provided Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Nov 17, 2021 | Published functional studies demonstrate a damaging effect due to protein misfolding and ER retention (Tamarappoo et al., 1998; Leduc-Nadeau et al., 2010); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 10564236, 10228154, 20403973, 11374071, 11076974, 14593099, 10997928, 7537761, 7524315, 15509592, 8140421, 9593782) - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 187 of the AQP2 protein (p.Arg187Cys). This variant is present in population databases (rs104894328, gnomAD 0.008%). This missense change has been observed in individuals with nephrogenic diabetes insipidus (NDI) in a family and also has been observed as homozygous or in combination with another AQP2 variant in individuals affected with NDI (PMID: 7524315, 20403973). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 17828). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt AQP2 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects AQP2 function (PMID: 9593782, 10228154, 10564236, 11374071, 20403973). For these reasons, this variant has been classified as Pathogenic. - |
Nephrogenic diabetes insipidus Pathogenic:2
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing;curation | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 18, 2011 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at